PT-141 is white powder, while it's Molecular Formula is C50H68N14O10. white powder Treatment of sexual dysfunction (melanocortin receptor agonist).Bremelanotide is used to treat low sexual desire in women who have not gone through menopause and have not had low sexual desire in the past.bremelanotide should be used only to treat low sexual desire that occurs with any type of sexual activity, in any sexual situation, or with any sexual partner.Bremelanotide should not be used to treat low sexual desire that is caused by relationship problems, health problems, mental illness, or by using certain drugs or medications.https://www.drugs.com

What is the CAS number for PT-141?

The CAS number of PT-141 is 189691-06-3.

What is PT-141 (189691-06-3) used for?

Bremelanotide (Vyleesi?) was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. Bremelanotide activates melanocortin receptors，but the mechanism by which it improves sexual desire is unknown. To use bremelanotide, women inject it under the skin ofthe abdomen or thigh at least 45 minutes before anticipated sexual activity.The optimal time to inject bremelanotide may vary based on the duration of benefit and side effects experienced. More than one dose of bremelanotide should not be used within 24 hours or more than eight doses per month. Common side effects include nausea, vomiting, flushing, injection site reactions, and headache. Bremelanotide should not be used in women with high blood pressure that is uncontrolled or in those with known cardiovascular disease, and it is not recommended for women at high risk for cardiovascular disease. The safety and efficacy of bremelanotide has not been studied in breast cancer survivors, and there are no recommendations regarding its use in this population.InChI:InChI=1/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41?/m0/s1

PT-141 is white powder, while it's Molecular Formula is C50H68N14O10. white powder Treatment of sexual dysfunction (melanocortin receptor agonist).Bremelanotide is used to treat low sexual desire in women who have not gone through menopause and have not had low sexual desire in the past.bremelanotide should be used only to treat low sexual desire that occurs with any type of sexual activity, in any sexual situation, or with any sexual partner.Bremelanotide should not be used to treat low sexual desire that is caused by relationship problems, health problems, mental illness, or by using certain drugs or medications.https://www.drugs.com

What is the CAS number for PT-141?

The CAS number of PT-141 is 189691-06-3.

What is PT-141 (189691-06-3) used for?

Bremelanotide (Vyleesi?) was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. Bremelanotide activates melanocortin receptors，but the mechanism by which it improves sexual desire is unknown. To use bremelanotide, women inject it under the skin ofthe abdomen or thigh at least 45 minutes before anticipated sexual activity.The optimal time to inject bremelanotide may vary based on the duration of benefit and side effects experienced. More than one dose of bremelanotide should not be used within 24 hours or more than eight doses per month. Common side effects include nausea, vomiting, flushing, injection site reactions, and headache. Bremelanotide should not be used in women with high blood pressure that is uncontrolled or in those with known cardiovascular disease, and it is not recommended for women at high risk for cardiovascular disease. The safety and efficacy of bremelanotide has not been studied in breast cancer survivors, and there are no recommendations regarding its use in this population.InChI:InChI=1/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41?/m0/s1

Products

Product classification

small-molecule inhibitor
intermediate
Pharmaceutical intermediate
Biochemical reagent
fire retardant
chemical reagent
ionic liquid
Inhibitor
Antibody
Pesticide
New materials
Customization
Nucleosides
Food additives
Supplement
API
Pharmaceutical intermediates

Contact us

Tel：+86-0533-2185556
Fax：+86-0533-2185556
Phone：WhatsApp: +86 15965530500
Website：https://www.shandonghangyubiotech.com
Email：admin@hangyubiotech.com
Address：Room 2516, Dingcheng Building, Beijing Road, Zhangdian District, Zibo City, Shandong Province

189691-06-3

Product Name:Bremelanotide
Molecular Formula:C₅₀H₆₈N₁₄O₁₀
Molecular Weight:1025.18
Appearance:white powder

Inquiry

Product Details

Appearance:white powder

Purity:99%

Factory Sells Best Quality Bremelanotide 189691-06-3 with USP

Molecular Formula:C50H68N14O10
Molecular Weight:1025.18
Appearance/Colour:white powder
Refractive Index:1.679
PKA:3.37±0.70(Predicted)
PSA：376.47000
Density:1.43 g/cm³
LogP:3.50620

Relevant Products

JORO SPIDER TOXIN JSTX-3
CAS：112163-33-4
cis-13-Docosenoamide
CAS：112-84-5
(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one
CAS：16251-45-9
HUMAN IGF-II
CAS：96081-16-2

Home

About us

Products

small-molecule inhibitor

intermediate

Pharmaceutical intermediate

Biochemical reagent

fire retardant

chemical reagent

ionic liquid

Inhibitor

Antibody

Pesticide

New materials

Customization

Nucleosides

Food additives

Supplement

API

Pharmaceutical intermediates

Biological products

Polypeptides

Chemical reagents

Small molecule inhibitors

Organic electronic chemical materials

Technical Support

News

Contact Us